Context Therapeutics Inc.

CNTX·NASDAQ·$2.63Share Price as of 11/2·$242MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202503/23/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report08/05/26 8-KCurrent report07/31/26 8-KCurrent report06/26/26 8-KCurrent report06/15/26 8-KCurrent report05/18/26

Prospectuses and Registrations

S-8Registration of securities for employees03/23/26 424B5Prospectus supplement10/24/25 S-8Registration of securities for employees03/20/25 424B5Prospectus supplement12/02/24 S-3Shelf registration11/06/24

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 PRE 14APreliminary proxy04/17/26 DEF 14ADefinitive proxy04/15/25 DEFA14AAdditional proxy materials04/15/25

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/12/26 SC 13G/ABeneficial ownership (amended)07/31/26 Form 4Insider transaction06/26/26 Form 4Insider transaction06/26/26

Other

ARSAnnual report to shareholders04/28/26 ARSAnnual report to shareholders04/15/25 EFFECTRequest for effectiveness11/14/24 CORRESPCorrespondence with the SEC11/12/24 UPLOADLetter from the SEC11/12/24